SOST and chronic kidney disease: We speculate that the elevated sclerostin may partly originate from atherosclerotic plaques in CKD patients, which suppresses atherosclerosis in a negative feedback mechanism by inhibiting Wnt signaling, thereby protecting against plaque development.